يعرض 1 - 10 نتائج من 11 نتيجة بحث عن '"Randeep Sangha"', وقت الاستعلام: 1.04s تنقيح النتائج
  1. 1
    First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

    المؤلفون: A. Vergnenegre, A. Alexandru, Hiroshi Sakai, Helena Linardou, Michael Schenker, Claudia Caserta, László Urbán, Judith Raimbourg, Jacobus A. Burgers, Arteid Memaj, Suresh S. Ramalingam, Matthew D. Hellmann, Randeep Sangha, Martin Reck, Julie R. Brahmer, Mariano Provencio, Ki Hyeong Lee, Sang-We Kim, Clarisse Audigier-Valette, Luis Paz-Ares, Yuichiro Ohe, Hossein Borghaei, Kenneth J. O'Byrne, L. Lupinacci, Phuong Tran, Jong Seok Lee, Makoto Nishio, Kynan Feeney, Masayuki Takeda, Enric Carcereny, Adam Pluzanski, F. E. Nathan, Carlos Gallardo, Judith Bushong, Keunchil Park, B. Zurawski, Tudor-Eliade Ciuleanu, Reyes Bernabe Caro, Gregory A. Otterson

    المساهمون: Bristol-Myers Squibb, Ono Pharmaceutical

    المصدر: Journal of Thoracic Oncology
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    instname

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Adult, medicine.medical_specialty, Lung Neoplasms, Immunotherapy, First line, medicine.medical_treatment, Ipilimumab, PD-1 checkpoint inhibitor, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Chemotherapy, CTLA-4, First-line, business.industry, Confidence interval, Discontinuation, Nivolumab, Metastatic non–small cell lung cancer, Open label, Neoplasm Recurrence, Local, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f7125153a7a538998a341b2f60e83eTest
    http://hdl.handle.net/10261/305831Test


    أضف إلى المفضلة
  2. 2
    EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma

    المؤلفون: Elaina M. Gartner, Elisabeth I. Heath, Matthew I. Milowsky, Randeep Sangha, Joshua M. Lang, David I. Quinn, J. Merchan, Elizabeth R. Plimack, Daniel P. Petrylak, Thomas W. Flaig, Jingsong Zhang, David Smith, Chunzhang Wu, Sandy Srinivas, Peiying Zuo, Srikala S. Sridhar, D. Ruether, Jonathan E. Rosenberg, Joaquina Baranda, Amal Melhem-Bertrandt

    المصدر: Journal of Clinical Oncology

    مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Urologic Neoplasms, Cancer Research, Metastatic Urothelial Carcinoma, Enfortumab vedotin, Genitourinary Cancer, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Nectin, Humans, Medicine, In patient, Aged, Aged, 80 and over, business.industry, Antibodies, Monoclonal, ORIGINAL REPORTS, Middle Aged, Immunohistochemistry, Phase i study, Survival Rate, 030104 developmental biology, Oncology, Tolerability, 030220 oncology & carcinogenesis, Cancer research, Female, business, Cell Adhesion Molecules, Conjugate

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::957e217a4be4cabe522d772b695e3213Test
    http://europepmc.org/articles/PMC7106979Test


    أضف إلى المفضلة
  3. 3
    A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

    المؤلفون: Florence Atrafi, Young Kwang Chae, Martijn P. Lolkema, Philip Komarnitsky, Lauren Averett Byers, Lei He, Tian Tian, Santiago Viteri, Beibei Hu, Silpa Nuthalapati, Randeep Sangha, Antonio Calles, Nashat Y. Gabrail, Elena Garralda, Harry J.M. Groen, Elizabeth Hoening, D. Ross Camidge

    المساهمون: Medical Oncology, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: Clinical Cancer Research, 25(2), 496-505. American Association for Cancer Research Inc.
    Clinical Cancer Research, 25(2), 496-505. AMER ASSOC CANCER RESEARCH

    مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, ABT-888, SINGLE-AGENT, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Etoposide, PLUS CARBOPLATIN, Middle Aged, CHEMOTHERAPY, Treatment Outcome, Tolerability, 030220 oncology & carcinogenesis, DNA-REPAIR, Female, TRIAL, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Veliparib, Neutropenia, GERMLINE BRCA1, OVARIAN-CANCER, 03 medical and health sciences, Pharmacokinetics, SDG 3 - Good Health and Well-being, Internal medicine, medicine, Humans, Adverse effect, PARP INHIBITOR VELIPARIB, COMBINATION, Aged, Neoplasm Staging, Chemotherapy, business.industry, medicine.disease, Small Cell Lung Carcinoma, 030104 developmental biology, chemistry, Benzimidazoles, business

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef576ddb32ba6e108376031f782f4658Test
    https://doi.org/10.1158/1078-0432.Ccr-18-2014Test


    أضف إلى المفضلة
  4. 4
    Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

    المؤلفون: Ki Hyeong Lee, Fiona Taylor, Romain Corre, F. E. Nathan, John R. Penrod, Rachael Lawrance, Martin Reck, Makoto Nishio, Yong Yuan, Michael DeRosa, Judith Raimbourg, Samreen Ahmed, Krzysztof Lesniewski-Kmak, Randeep Sangha, Eduardo Richardet, Mariano Provencio, Julie R. Brahmer, Fabio Franke, Kynan Feeney, Michael Schenker, Prabhu Bhagavatheeswaran

    المساهمون: UAM. Departamento de Medicina

    المصدر: Biblos-e Archivo. Repositorio Institucional de la UAM
    instname

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, Health Status, 0302 clinical medicine, Antineoplastic Agents, Immunological, Lung neoplasms, Carcinoma, Non-Small-Cell Lung, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Nivoluma, education.field_of_study, Middle Aged, Nivolumab, 030220 oncology & carcinogenesis, Female, medicine.drug, Quality of life, Adult, medicine.medical_specialty, Visual analogue scale, Medicina, Population, Ipilimumab, Nonesmall-cell lung cancer, 03 medical and health sciences, Internal medicine, medicine, Humans, Patient Reported Outcome Measures, Lung cancer, education, Aged, business.industry, Carcinoma, Repeated measures design, medicine.disease, Discontinuation, Clinical trial, 030104 developmental biology, Quality of Life, Platinum-doublet chemotherapy, business, Surveys and questionnaires

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cafa90a6b0e0fe0dd56ea8ed396707eTest
    https://pubmed.ncbi.nlm.nih.gov/31195357Test


    أضف إلى المفضلة
  5. 5
    Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy

    المؤلفون: Michael P, Chu, Jessica, Lieffers, Sunita, Ghosh, Andrew, Belch, Neil S, Chua, Amelie, Fontaine, Randeep, Sangha, Robert A, Turner, Vickie E, Baracos, Michael B, Sawyer

    المصدر: Journal of Cachexia, Sarcopenia and Muscle

    مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Sarcopenia, Cachexia, Diffuse large B‐cell lymphoma, Original Articles, Middle Aged, Prognosis, Skeletal muscle radiodensity, Young Adult, Antineoplastic Agents, Immunological, Treatment Outcome, hemic and lymphatic diseases, Humans, Female, Original Article, Lymphoma, Large B-Cell, Diffuse, Muscle, Skeletal, Rituximab, Tomography, X-Ray Computed, Aged

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::a829236e474a7afc9f0b7130d1ac9d0fTest
    https://pubmed.ncbi.nlm.nih.gov/27897411Test


    أضف إلى المفضلة
  6. 6
    Intercalated Erlotinib-Docetaxel Dosing Schedules Designed to Achieve Pharmacodynamic Separation: Results of a Phase I/II Trial

    المؤلفون: Natasha Perkins, Laurel A. Beckett, Primo N. Lara, Paul J. Hesketh, Tianhong Li, Philip C. Mack, Derick H Lau, David R. Gandara, Angela M. Davies, Randeep Sangha

    المصدر: Journal of Thoracic Oncology. 6(12):2112-2119

    مصطلحات موضوعية: Oncology, Adult, Diarrhea, Male, Mucositis, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Neutropenia, Combination therapy, medicine.medical_treatment, Kaplan-Meier Estimate, Docetaxel, Pharmacology, Article, Disease-Free Survival, Erlotinib Hydrochloride, Non-small cell lung cancer, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, neoplasms, Aged, Aged, 80 and over, Chemotherapy, business.industry, Middle Aged, medicine.disease, Pharmacodynamic separation, Phase II, Erlotinib, Pharmacodynamics, Quinazolines, Female, Taxoids, business, Febrile neutropenia, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91809eb90f738212eca55e49f77f760eTest


    أضف إلى المفضلة
  7. 7
    Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy

    المؤلفون: Michael P. Chu, Andrew R. Belch, Neil Chua, A. Robert Turner, Jessica R L Lieffers, Amelie Fontaine, Randeep Sangha, Michael B. Sawyer, Sunita Ghosh, Vickie E. Baracos

    المصدر: PLoS ONE
    PLoS ONE, Vol 10, Iss 6, p e0127589 (2015)

    مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Follicular lymphoma, lcsh:Medicine, Disease-Free Survival, International Prognostic Index, Chemoimmunotherapy, Internal medicine, Hounsfield scale, Medicine, Humans, Stage (cooking), lcsh:Science, Muscle, Skeletal, Lymphoma, Follicular, Aged, Demography, Aged, 80 and over, Multidisciplinary, business.industry, Hazard ratio, lcsh:R, Middle Aged, medicine.disease, Surgery, Lymphoma, Radiography, Treatment Outcome, Sarcopenia, Multivariate Analysis, lcsh:Q, Female, Immunotherapy, business, Research Article

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::696d22001f46eee9d76dee80ecaa2530Test
    http://europepmc.org/articles/PMC4452316Test


    أضف إلى المفضلة
  8. 8
    Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study

    المؤلفون: Ian W. Flinn, Oliver W. Press, Robert Kahn, Sarit Assouline, Franck Morschhauser, Surai Jones, Anton Hagenbeek, Maria Corinna Palanca-Wessels, Olivier Casasnovas, Ranjana H. Advani, Randall C. Dere, Myron S. Czuczman, Manish R. Patel, Hervé Tilly, Sreeni Yalamanchili, Laurie H. Sehn, Dan Lu, Gilles Salles, Randeep Sangha, Cheryl Jones, Yu Waye Chu

    المساهمون: Clinical Haematology

    المصدر: lancet oncology, 16(6), 704-715. Lancet Publishing Group

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Antibody-drug conjugate, Immunoconjugates, Neutropenia, Gastroenterology, Drug Administration Schedule, Antibodies, Monoclonal, Murine-Derived, Refractory B-Cell Non-Hodgkin Lymphoma, immune system diseases, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Aged, Aged, 80 and over, business.industry, Lymphoma, Non-Hodgkin, Antibodies, Monoclonal, Middle Aged, medicine.disease, Prognosis, Leukemia, Lymphocytic, Chronic, B-Cell, Polatuzumab vedotin, Surgery, Oncology, Tolerability, Rituximab, Female, business, Progressive disease, Febrile neutropenia, CD79 Antigens, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8dfd6e04690729d46c6a6ebeeb92d9fTest
    https://pubmed.ncbi.nlm.nih.gov/25925618Test


    أضف إلى المفضلة
  9. 9
    A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors

    المؤلفون: Evangelos D. Michelakis, Peter Venner, John R. Mackey, Alexander J.B. McEwan, Randeep Sangha, Larissa J. Vos, Quincy Siu-Chung Chu, Jennifer L. Spratlin

    المصدر: Investigational new drugs. 33(3)

    مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Nausea, Urology, Antineoplastic Agents, Pharmacology, Cohort Studies, Pharmacokinetics, Neoplasms, medicine, Humans, Pharmacology (medical), In patient, Aged, Neoplasm Staging, Dichloroacetic Acid, Dose-Response Relationship, Drug, business.industry, Cancer, Middle Aged, medicine.disease, Diarrhea, Oncology, Toxicity, Cohort, Vomiting, Female, medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ead44261d203d7d54714e2c2846ad9d5Test
    https://pubmed.ncbi.nlm.nih.gov/25762000Test


    أضف إلى المفضلة
  10. 10
    EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer

    المؤلفون: David R. Gandara, Yueju Li, Laurel A. Beckett, Rebekah A. Burich, Randeep Sangha, Primo N. Lara, W. S. Holland, Philip C. Mack, Leslie J. Solis, Angela M. Davies

    المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 4(12)

    مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, Docetaxel, medicine.disease_cause, NSCLC, Polymerase Chain Reaction, T790M, Plasma, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Epidermal growth factor receptor, Erlotinib Hydrochloride, 0303 health sciences, biology, DNA, Neoplasm, Middle Aged, Resistance mutation, Prognosis, 3. Good health, ErbB Receptors, Treatment Outcome, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, KRAS, medicine.drug, Pulmonary and Respiratory Medicine, Adult, medicine.medical_specialty, Genotype, EGFR, Adenocarcinoma, Proto-Oncogene Proteins p21(ras), 03 medical and health sciences, Internal medicine, Proto-Oncogene Proteins, medicine, Biomarkers, Tumor, Humans, Lung cancer, neoplasms, 030304 developmental biology, Aged, Neoplasm Staging, business.industry, medicine.disease, respiratory tract diseases, Mutation, biology.protein, Quinazolines, ras Proteins, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407171a69ac8c48dea52d7756cede788Test
    https://pubmed.ncbi.nlm.nih.gov/19884861Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث